October 29, 2013


9–9:05 a.m.           WELCOME

9:05–9:30 a.m.     KEYNOTE: The State of Cancer Care: Promises and Challenges

                                  Harold Varmus, M.D., Director, National Cancer Institute

9:30–10:30 a.m.   The State of Genomic Understanding

How advances in genomics and bioinformatics are providing us with unprecedented opportunities to understand cancer biology and "exceptional responders".

Tadd Lazarus, M.D., Chief Medical Officer, Qiagen Inc. (Moderator)

Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School Director Emeritus, Harvard Medical School-Partners HealthCare Center for Personalized Genetic Medicine

David Solit, M.D., Elizabeth and Felix Rohatyn Chair, Department of Medicine and the Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center

10:30–10:45 a.m.    BREAK

10:45–11:50 a.m.    Detection and Prognosis: The Cutting Edge

How innovations in diagnostics technologies will transform cancer detection and care.

Paul Billings, M.D., Ph.D., Chief Medical Officer, Life Technologies Corp. (Moderator)

Luis Diaz Jr., M.D., Associate Professor of Oncology and Director of Translational Medicine, Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center

David Rimm, M.D., Ph.D., Professor of Pathology, Director of Pathology Tissue Services, and Director of Translational Pathology, Yale University

Laura van 't Veer, Ph.D., Leader, Breast Oncology Program and Associate Director, Applied Genomics, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center

Victor Velculescu, M.D., Ph.D., Professor of Oncology, Director of Cancer Genetics, Ludwig Center at Johns Hopkins, Co-director of Cancer Biology, Johns Hopkins Kimmel Cancer Center

11:50 a.m.-12 p.m.  Special Recognition

Jack Andraka, winner 2012 Gordon E. Moore Award, the grand prize of the Intel International Science and Engineering Fair, for his "new method to detect pancreatic cancer".

12-1:30 p.m.          LUNCHEON KEYNOTE: Path to Personalized Medicine - Where Are We Today?

Francis Collins, M.D., Ph.D, Director of the National Institutes of Health

Margaret Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration

A conversation on the state of personalized medicine moderated by Charles Sawyers, M.D., President, American Association for Cancer Research, Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

1:30–1:45 p.m.       BREAK

1:45–3 p.m.            Ensuring Patient Safety and Innovation

How diagnostics regulatory pathways can promote patient safety and innovation.

Daniel Hayes, M.D., Professor, Department of Internal Medicine, Stuart B. Padnos Professor of Breast Cancer Research, Clinical Director, Breast Oncology Program, University of Michigan (Moderator)

Tracy Bush, Ph.D., Director and Global Coordinator of Companion Diagnostics Regulatory Affairs, Roche Diagnostics

Elizabeth Mansfield, Ph.D., Director, Personalized Medicine Staff, Center for Devices and Radiological Health, Food and Drug Administration

Vincent Miller, M.D., Chief Medical Officer, Foundation Medicine

Ellen Sigal, Ph.D., Founder and Chair, Friends of Cancer Research

3–4:15 p.m.            Ensuring Patient Access to Innovative Diagnostics

How current payment systems value new diagnostic technologies and affect physician and patient access

Louis Jacques, M.D., Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services

John Powderly, M.D., Founder, Carolina BioOncology Institute

Michele Schoonmaker, Vice President of Government Affairs, Cepheid

4:15 p.m.               CLOSING REMARKS